Biocidal Products Regulation

The Biocidal Product Regulation (BPR, Regulation (EU) 528/2012) concerns the placing on the market and use of biocidal products, which are used to protect humans, animals, materials or articles against harmful organisms, like pests or bacteria, by the action of the active substances contained in the biocidal product.

Understanding BPR

 

Legislation

Processes

 

Image

Companies can apply for the approval or the inclusion in Annex I of an active substance by submitting a dossier to ECHA.
 

Image

After the approval of an active substance, companies wishing to place biocidal products on the market have to apply for product authorisation at national or Union level.
 

 

Image

Companies can ask ECHA to establish the technical equivalence or the chemical similarity of their active substance.
 

Image

Manufacturers and importers not involved with the review programme of the previous legislation have to submit certain information to ECHA.

 


 

 

Image

A fundamental and new aspect of the Biocidal Products Regulation is the common obligation to share information about active substances and products approved and authorised in the EU.
 

Nanomaterials and the Biocidal Products Regulation

The provisions for nanomaterials apply to products and substances which meet the criteria defined in the Biocidal Products Regulation. These definitions are based on the Commission recommendation on the definition of nanomaterials.
 
 

Treated articles

The Biocidal Products Regulation (BPR) sets rules for the use of articles treated with, or intentionally incorporating, one or more biocidal products.
 
 

Research and development

Any tests and experiments carried out for research and development purposes using unauthorised biocidal products and their (not approved) active substances must be recorded and may require notifications if a release in the environment is possible.